Abivax S.A. Adjustments For Share-based Payments
Abivax S.A. (ABVX) reported Adjustments For Share-based Payments of EUR 35.40 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2026-03-23
- Abivax S.A. adjustments for share-based payments for the quarter ending 2025-12-31 was 12.90M EUR, a 189.43% increase year-over-year.
- Abivax S.A. adjustments for share-based payments for the quarter ending 2025-09-30 was 11.48M EUR, a 164.06% increase year-over-year.
- Abivax S.A. adjustments for share-based payments for the quarter ending 2025-06-30 was 6.33M EUR, a 11.75% increase year-over-year.
- Abivax S.A. adjustments for share-based payments for the quarter ending 2025-03-31 was 4.69M EUR, a 18.52% decline year-over-year.
| Period end | Adjustments For Share-based Payments 3 month | Adjustments For Share-based Payments 6 month | Adjustments For Share-based Payments 9 month | Adjustments For Share-based Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | 12.90M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 24.38M EUR derived: sum of 2 quarters · filed 2026-03-23 | 30.71M EUR derived: sum of 3 quarters · filed 2026-03-23 | 35.40M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 11.48M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | 17.81M EUR derived: sum of 2 quarters · filed 2025-12-15 | 22.50M EUR 6-K · filed 2025-12-15 | 26.95M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | 6.33M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | 11.02M EUR 6-K · filed 2025-09-08 | 15.48M EUR derived: sum of 3 quarters · filed 2026-03-23 | 19.82M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | 4.69M EUR 6-K · filed 2025-06-02 | 9.15M EUR derived: sum of 2 quarters · filed 2026-03-23 | 13.49M EUR derived: sum of 3 quarters · filed 2026-03-23 | 19.16M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | 4.46M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 8.80M EUR derived: sum of 2 quarters · filed 2026-03-23 | 14.47M EUR derived: sum of 3 quarters · filed 2026-03-23 | 20.22M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 4.35M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | 10.01M EUR derived: sum of 2 quarters · filed 2025-12-15 | 15.77M EUR 6-K · filed 2025-12-15 | |
| 2024-06-30 | 5.67M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | 11.42M EUR 6-K · filed 2025-09-08 | ||
| 2024-03-31 | 5.75M EUR 6-K · filed 2025-06-02 | |||
| 2023-12-31 | 8.18M EUR 20-F · filed 2026-03-23 | |||
| 2022-12-31 | -1.16M EUR 20-F · filed 2025-03-24 | |||
| 2021-12-31 | 828.00K EUR 20-F · filed 2024-04-05 |